Change - Announcement of Appointment::Appointment of Chief Executive Officer, Thomson Medical Centre

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$225M4.8%N220718 - SGXF90488481 - YRYB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
30-Jun-2022 17:40:09
Status
New
Announcement Sub Title
Appointment of Chief Executive Officer, Thomson Medical Centre
Announcement Reference
SG220630OTHR1E7N
Submitted By (Co./ Ind. Name)
Dr Wong Chiang Yin
Designation
Executive Director and Group Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Appointment of Dr Daniel Lee Hsien Chieh as Chief Executive Officer, Thomson Medical Centre with effect from 1 July 2022.

Additional Details

Date Of Appointment
01/07/2022
Name Of Person
Dr Daniel Lee Hsien Chieh
Age
42
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board of Directors of the Company, having considered the recommendation of the Nominating and Remuneration Committee (NRC) and having reviewed and considered Dr Lee's qualifications and work experience, is of the view that Dr Lee possesses the requisite experience and qualifications. Accordingly, the NRC recommended, and the Board has approved the appointment of Dr Lee as the Chief Executive Officer, Thomson Medical Centre with effect from 1 July 2022.
Whether appointment is executive, and if so, the area of responsibility
Executive and to oversee the business operations of hospital services in Singapore.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer, Thomson Medical Centre
Professional qualifications
Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore
Graduate Diploma in Family Medicine (GDFM), National University of Singapore
Master of Public Health (MPH), Harvard University
Public Health Specialist, Specialists Accreditation Board
Fellow, Academy of Medicine Singapore (FAMS)
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
General Manager and Chief Operating Officer
Thomson Medical Centre
Dec 2020 - present

Senior Director, Operations
Thomson Medical Centre
Dec 2018 - Nov 2020

Deputy Director, Clinical Services
Changi General Hospital
Sep 2013 - Dec 2018

Assistant Director, Operations
Changi General Hospital
June 2011 - Aug 2013
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
Director of:
Thomson Medical Pte Ltd
Thomson Diagnostic Imaging Pte Ltd
Thomson Pre-natal Diagnostic Laboratory Pte Ltd
Singapore Medical Association Pte Ltd

Management Committee Member
St Andrew s Community Hospital
Since 2021

Council Member
Advertising Standards Authority of Singapore
Since 2020

Council Member
Singapore Medical Association
Since 2012

Executive Committee Member
Fulbright Association (Singapore)
Since 2011
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
None
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
NA